NCT05800925 Triage Survey for Psychiatry Research Eligibility
| NCT ID | NCT05800925 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Adams Clinical |
| Condition | Major Depressive Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 20,000 participants |
| Start Date | 2021-12-21 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20,000 participants in total. It began in 2021-12-21 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
TRIAGE-Psych is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored psychiatry clinical trials.
Eligibility Criteria
Inclusion Criteria: * Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed. * Participant is at least 18 years old. Exclusion Criteria: * Participant is pregnant, breast-feeding, or planning to become pregnant. * History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results. * Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on C-SSRS questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening. * Moderate or severe substance use disorder within 90 days prior to screen, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant. * Any condition that in the investigator's opinion makes a participant unsuitable for the study. * Currently employed by Adams Clinical or a first-degree relative of an employee.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05800925 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Major Depressive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05800925 currently recruiting?
Yes, NCT05800925 is actively recruiting participants. Contact the research team at mevans@adamsclinical.com for enrollment information.
Where is the NCT05800925 trial being conducted?
This trial is being conducted at Boston, United States, Watertown, United States, New York, United States, The Bronx, United States and 2 additional locations.
Who is sponsoring the NCT05800925 clinical trial?
NCT05800925 is sponsored by Adams Clinical. The trial plans to enroll 20,000 participants.